A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/496 (2006.01) A61P 25/16 (2006.01)
Patent
CA 2480266
The invention relates to a method for the treatment of symptoms of disorders and conditions with sensorimotor gating deficits with an alpha2-adrenoceptor antagonist, or its pharmaceutically acceptable ester or salt thereof, being selective for the alpha2C-adrenoceptor subtype.
L'invention concerne un procédé pour traiter les symptômes des troubles et états liés au manque de filtrage sélectif ("gating") sensori-moteur avec un antagoniste d'alfa2-adrénorécepteur ou un ester pharmaceutiquement acceptable ou son sel, sélectif vis-à-vis du sous-type alpha2C-adrénocepteur.
Sallinen Jukka
Sirvioe Jouni
Orion Corporation
Oy Juvantia Pharma Ltd
Robic
LandOfFree
Use of an alpha2-adrenoreceptor antagonist for cns-related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of an alpha2-adrenoreceptor antagonist for cns-related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of an alpha2-adrenoreceptor antagonist for cns-related... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1349293